{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:56:13Z","timestamp":1760298973949,"version":"3.37.3"},"reference-count":31,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T00:00:00Z","timestamp":1406160000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T00:00:00Z","timestamp":1406160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"APEX Grant","award":["1002\/PPSP\/910340"],"award-info":[{"award-number":["1002\/PPSP\/910340"]}]},{"DOI":"10.13039\/501100004595","name":"Universiti Sains Malaysia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004595","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1111\/jcpt.12197","type":"journal-article","created":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T08:02:40Z","timestamp":1406188960000},"page":"685-690","source":"Crossref","is-referenced-by-count":16,"title":["Clinical impact of<i>ABCC1<\/i>and<i>ABCC2<\/i>genotypes and haplotypes in mediating imatinib resistance among chronic myeloid leukaemia patients"],"prefix":"10.1155","volume":"39","author":[{"given":"A.","family":"Au","sequence":"first","affiliation":[{"name":"Human Genome Centre; School of Medical Sciences; Universiti Sains Malaysia; Kubang Kerian Kelantan Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Hematology; School of Medical Sciences; Universiti Sains Malaysia; Kubang Kerian Kelantan Malaysia"},{"name":"School of Medicine; International Medical University; Bukit Jalil Kuala Lumpur Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Azlan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Hematology; School of Medical Sciences; Universiti Sains Malaysia; Kubang Kerian Kelantan Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Norsa'adah","sequence":"additional","affiliation":[{"name":"Unit of Biostatistics and Research Methodology; School of Medical Sciences; Universiti Sains Malaysia; Kubang Kerian Kelantan Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ankathil","sequence":"additional","affiliation":[{"name":"Human Genome Centre; School of Medical Sciences; Universiti Sains Malaysia; Kubang Kerian Kelantan Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,7,24]]},"reference":[{"key":"10.1111\/jcpt.12197-BIB0001|jcpt12197-cit-0001","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1158\/1078-0432.CCR-09-1068","article-title":"Mechanisms of resistance to imatinib and second-generation tyrosine inhibitors in chronic myeloid leukemia","volume":"15","author":"Milojkovic","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1111\/jcpt.12197-BIB0002|jcpt12197-cit-0002","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.leukres.2013.12.025","article-title":"BCR-ABL kinase domain mutations, including 2 novel mutations in imatinib resistant Malaysian chronic myeloid leukemia patients-frequency and clinical outcome","volume":"38","author":"Elias","year":"2014","journal-title":"Leuk Res"},{"key":"10.1111\/jcpt.12197-BIB0003|jcpt12197-cit-0003","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1182\/blood-2007-10-116475","article-title":"Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study","volume":"111","author":"Larson","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jcpt.12197-BIB0004|jcpt12197-cit-0004","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bbalip.2009.01.007","article-title":"Emerging new paradigms for ABCG transporters","volume":"1791","author":"Tarr","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/jcpt.12197-BIB0005|jcpt12197-cit-0005","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4149\/neo_2009_03_202","article-title":"Imatinib is a substrate for various multidrug resistance proteins","volume":"56","author":"Czyzewski","year":"2009","journal-title":"Neoplasma"},{"key":"10.1111\/jcpt.12197-BIB0006|jcpt12197-cit-0006","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.biopha.2014.01.009","article-title":"Association of genotypes and haplotypes of multi-drug transporter genes ABCB1 and ABCG2 with clinical response to imatinib mesylate in chronic myeloid leukemia patients","volume":"68","author":"Au","year":"2014","journal-title":"Biomed Pharmacother"},{"key":"10.1111\/jcpt.12197-BIB0007|jcpt12197-cit-0007","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/tpj.2010.20","article-title":"Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function","volume":"11","author":"Laechelt","year":"2011","journal-title":"Pharmacogenomics J"},{"key":"10.1111\/jcpt.12197-BIB0008|jcpt12197-cit-0008","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","article-title":"Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet","volume":"27","author":"Baccarani","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1111\/jcpt.12197-BIB0009|jcpt12197-cit-0009","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bcp.2008.09.019","article-title":"ABCB1 and ABCC1 expression in peripheral mononuclear cells is influenced by gene polymorphisms and atorvastatin treatment","volume":"77","author":"Rebecchi","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/jcpt.12197-BIB0010|jcpt12197-cit-0010","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1440-1681.2011.05571.x","article-title":"ABCC1 polymorphism Arg723Gln (2168G> A) is associated with lung cancer susceptibility in a Chinese population","volume":"38","author":"Yin","year":"2011","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1111\/jcpt.12197-BIB0011|jcpt12197-cit-0011","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.tpj.6500403","article-title":"Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex","volume":"7","author":"Haenisch","year":"2007","journal-title":"Pharmacogenomics J"},{"key":"10.1111\/jcpt.12197-BIB0012|jcpt12197-cit-0012","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1182\/blood-2008-03-147744","article-title":"Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia","volume":"112","author":"Dulucq","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jcpt.12197-BIB0013|jcpt12197-cit-0013","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4161\/cbt.4.7.1826","article-title":"Research paper chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps","volume":"4","author":"Burger","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"10.1111\/jcpt.12197-BIB0014|jcpt12197-cit-0014","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0925-4439(02)00095-9","article-title":"Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1","volume":"1587","author":"Heged\u0171s","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/jcpt.12197-BIB0015|jcpt12197-cit-0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0304-3835(02)00359-2","article-title":"Reversal of P-glycoprotein mediated multidrug resistance by a newly synthesized 1, 4-benzothiazepine derivative, JTV-519","volume":"187","author":"Che","year":"2002","journal-title":"Cancer Lett"},{"key":"10.1111\/jcpt.12197-BIB0016|jcpt12197-cit-0016","first-page":"5902","article-title":"Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells","volume":"54","author":"Cole","year":"1994","journal-title":"Cancer Res"},{"key":"10.1111\/jcpt.12197-BIB0017|jcpt12197-cit-0017","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s100380170017","article-title":"Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution","volume":"46","author":"Conrad","year":"2001","journal-title":"J Hum Genet"},{"key":"10.1111\/jcpt.12197-BIB0018|jcpt12197-cit-0018","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/FPC.0b013e328323f680","article-title":"Characterization and analyses of multidrug resistance-associated protein 1 (MRP1\/ABCC1) polymorphisms in Chinese population","volume":"19","author":"Yin","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1111\/jcpt.12197-BIB0019|jcpt12197-cit-0019","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1742-7843.2010.00627.x","article-title":"Phenotype prediction of non-synonymous single-nucleotide polymorphisms in human ATP-binding cassette transporter genes","volume":"108","author":"Wang","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1111\/jcpt.12197-BIB0020|jcpt12197-cit-0020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/FPC.0b013e328343dd5f","article-title":"ABCC1 G2012T single nucleotide polymorphism is associated with patient outcome in primary neuroblastoma and altered stability of the ABCC1 gene transcript","volume":"21","author":"Pajic","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1111\/jcpt.12197-BIB0021|jcpt12197-cit-0021","first-page":"2227","article-title":"Association between single nucleotide polymorphisms of drug resistance-associated genes and response to chemotherapy in advanced ovarian cancer","volume":"26","author":"Obata","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1111\/jcpt.12197-BIB0022|jcpt12197-cit-0022","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1182\/blood-2002-05-1366","article-title":"High levels of BAX, low levels of MRP-1, and high platelets are independent predictors of response to imatinib in myeloid blast crisis of CML","volume":"101","author":"Lange","year":"2003","journal-title":"Blood"},{"key":"10.1111\/jcpt.12197-BIB0023|jcpt12197-cit-0023","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.4238\/vol7-4gmr482","article-title":"MRP1 polymorphisms (T2684C, C2007T, C2012T, and C2665T) are not associated with multidrug resistance in leukemic patients","volume":"7","author":"Mahjoubi","year":"2008","journal-title":"Genet Mol Res"},{"key":"10.1111\/jcpt.12197-BIB0024|jcpt12197-cit-0024","first-page":"4124","article-title":"A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation","volume":"56","author":"Taniguchi","year":"1996","journal-title":"Cancer Res"},{"key":"10.1111\/jcpt.12197-BIB0025|jcpt12197-cit-0025","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1086\/302292","article-title":"Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2\/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome","volume":"64","author":"Toh","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1111\/jcpt.12197-BIB0026|jcpt12197-cit-0026","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.21214","article-title":"Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver","volume":"44","author":"Meier","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/jcpt.12197-BIB0027|jcpt12197-cit-0027","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/FPC.0b013e328338073a","article-title":"A nonsynonymous variation in MRP2\/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy","volume":"20","author":"Kim","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"10.1111\/jcpt.12197-BIB0028|jcpt12197-cit-0028","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/jhg.2010.98","article-title":"Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia","volume":"55","author":"Takahashi","year":"2010","journal-title":"J Hum Genet"},{"key":"10.1111\/jcpt.12197-BIB0029|jcpt12197-cit-0029","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/cncr.22760","article-title":"Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer","volume":"110","author":"Han","year":"2007","journal-title":"Cancer"},{"key":"10.1111\/jcpt.12197-BIB0030|jcpt12197-cit-0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10637-006-6335-5","article-title":"Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes","volume":"24","author":"Zamboni","year":"2006","journal-title":"Invest New Drugs"},{"key":"10.1111\/jcpt.12197-BIB0031|jcpt12197-cit-0031","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1755-5949.2012.00336.x","article-title":"ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients","volume":"18","author":"Qu","year":"2012","journal-title":"CNS Neurosci Ther"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12197","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12197","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12197\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:05:34Z","timestamp":1671818734000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,24]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12197","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"type":"print","value":"0269-4727"}],"subject":[],"published":{"date-parts":[[2014,7,24]]}}}